Cargando…
Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review
Clostridium difficile infection (CDI) is a major cause of morbidity and mortality in patients with inflammatory bowel disease (IBD), especially in ulcerative colitis (UC). The incidence and severity of CDI in IBD has shown an increasing trend in the last two decades. Patients with IBD are predispose...
Autores principales: | Romana, Bhupinder S., Albarrak, Abdulmajeed A., Yousef, Mohamad H., Tahan, Veysel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323562/ https://www.ncbi.nlm.nih.gov/pubmed/30688931 http://dx.doi.org/10.14744/nci.2017.79446 |
Ejemplares similares
-
Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
por: Abu Khalaf, Suha, et al.
Publicado: (2020) -
Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
por: Mir, Fazia A., et al.
Publicado: (2018) -
Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series
por: Markovic, Srdjan, et al.
Publicado: (2021) -
Elderly donor graft for liver transplantation: Never too late
por: Chela, Harleen, et al.
Publicado: (2017) -
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
por: Loftus, Edward V, et al.
Publicado: (2022)